Literature DB >> 20088595

Analysis of monomeric and dimeric phosphorylated forms of protein kinase R.

Eric Anderson1, Christine Quartararo, Raymond S Brown, Yu Shi, Xudong Yao, James L Cole.   

Abstract

PKR (protein kinase R) is induced by interferon and is a key component of the innate immunity antiviral pathway. Upon binding double-stranded RNA (dsRNA) or dimerization in the absence of dsRNA, PKR undergoes autophosphorylation at multiple serines and threonines that activate the kinase. Although it has previously been demonstrated that phosphorylation enhances PKR dimerization, gel filtration analysis reveals a second monomeric phosphorylated form. These forms are termed phosphorylated dimeric PKR (pPKRd) and phosphorylated monomeric PKR (pPKRm). These two forms do not reversibly interconvert. Sedimentation equilibrium measurements reveal that pPKRm dimerizes weakly with a K(d) similar to that of unphosphorylated PKR. Isoelectric focusing and mass spectrometry demonstrate that both pPKRm and pPKRd are heterogeneous in their phosphorylation states, with an average of 9 or 10 phosphates. Equilibrium chemical denaturation analysis indicates that phosphorylation destabilizes the kinase domain by approximately 1.5 kcal/mol in the dimeric form but not in the monomeric form. Limited proteolysis also reveals that phosphorylation induces a conformational change in pPKRd that is not detected in pPKRm. pPKRm binds dsRNA with an affinity similar to that of unphosphorylated PKR, whereas binding cannot be detected with pPKRd. Despite these substantial differences in biophysical properties, both pPKRm and pPKRd are catalytically competent and are activated to phosphorylate the PKR substrate eIF2alpha in the absence of dsRNA. Thus, both monomeric and dimeric forms of phosphorylated PKR may participate in the interferon antiviral pathway.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20088595      PMCID: PMC2819637          DOI: 10.1021/bi901873p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  37 in total

1.  Phosphorylation of the RNA-dependent protein kinase regulates its RNA-binding activity.

Authors:  N V Jammi; P A Beal
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

Review 2.  Activation loop phosphorylation and catalysis in protein kinases: is there functional evidence for the autoinhibitor model?

Authors:  Joseph A Adams
Journal:  Biochemistry       Date:  2003-01-28       Impact factor: 3.162

Review 3.  Regulation of protein kinases; controlling activity through activation segment conformation.

Authors:  Brad Nolen; Susan Taylor; Gourisankar Ghosh
Journal:  Mol Cell       Date:  2004-09-10       Impact factor: 17.970

4.  Analysis of heterogeneous interactions.

Authors:  James L Cole
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

5.  Analysis of heterologous interacting systems by sedimentation velocity: curve fitting algorithms for estimation of sedimentation coefficients, equilibrium and kinetic constants.

Authors:  Walter F Stafford; Peter J Sherwood
Journal:  Biophys Chem       Date:  2004-03-01       Impact factor: 2.352

6.  Hepatitis C virus envelope protein E2 does not inhibit PKR by simple competition with autophosphorylation sites in the RNA-binding domain.

Authors:  D R Taylor; B Tian; P R Romano; A G Hinnebusch; M M Lai; M B Mathews
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

7.  Improved ultracentrifuge cells for high-speed sedimentation equilibrium studies with interference optics.

Authors:  A T Ansevin; D E Roark; D A Yphantis
Journal:  Anal Biochem       Date:  1970-03       Impact factor: 3.365

8.  Structural requirements of double-stranded RNA for the activation of 2',5'-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells.

Authors:  M A Minks; D K West; S Benvin; C Baglioni
Journal:  J Biol Chem       Date:  1979-10-25       Impact factor: 5.157

9.  Analysis of PKR structure by small-angle scattering.

Authors:  Jennifer VanOudenhove; Eric Anderson; Susan Krueger; James L Cole
Journal:  J Mol Biol       Date:  2009-02-14       Impact factor: 5.469

10.  Biochemical analyses of multiple fractions of PKR purified from Escherichia coli.

Authors:  Zan Xu; Die Wang; Xavier Lee; Bryan R G Williams
Journal:  J Interferon Cytokine Res       Date:  2004-09       Impact factor: 2.607

View more
  4 in total

1.  Analysis of PKR activation using analytical ultracentrifugation.

Authors:  James L Cole
Journal:  Macromol Biosci       Date:  2010-07-07       Impact factor: 4.979

2.  Mechanism of Protein Kinase R Inhibition by Human Cytomegalovirus pTRS1.

Authors:  Heather A Vincent; Benjamin Ziehr; Nathaniel J Moorman
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

3.  Raf kinase inhibitor protein (RKIP) dimer formation controls its target switch from Raf1 to G protein-coupled receptor kinase (GRK) 2.

Authors:  Katharina Deiss; Caroline Kisker; Martin J Lohse; Kristina Lorenz
Journal:  J Biol Chem       Date:  2012-05-17       Impact factor: 5.157

4.  Heparin activates PKR by inducing dimerization.

Authors:  Eric Anderson; Willythssa S Pierre-Louis; C Jason Wong; Jeffrey W Lary; James L Cole
Journal:  J Mol Biol       Date:  2011-09-28       Impact factor: 5.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.